MPH Health Care AG (93M1.DE) Stock Analysis & Winston Score
MPH Health Care AG is a German healthcare holding company that invests in and manages businesses across the pharmaceutical and medical sectors. Its portfolio includes stakes in specialty drug companies and healthcare service providers, with end customers ranging from hospitals and pharmacies to individual patients. The company operates primarily in the German-speaking European market. MPH generates revenue mainly through dividends, management fees, and profit distributions from its subsidiary and portfolio companies, rather than selling products directly to consumers. It is a small-cap firm with a market capitalization of around $0.1 billion, and its 100% gross margin reflects its holding-company structure where costs sit at the operating level of its investees. The key growth driver is its ability to identify and acquire undervalued healthcare assets in a fragmented European market, while the main risk is concentration — if one or two portfolio companies underperform, it can meaningfully hurt overall results.
Winston Score: 64/100 — Good
A decent business — some strong pillars, some weaker.
- Quality: Strong (23/30)
- Growth: Mixed (7/20)
- Cash Flow: Weak (2/10)
- Stability: Exceptional (10/10)
- Valuation: Strong (7/10)
- Ownership: Good (10/15)
Key Facts
Price: €23.90
Market Cap: €102M
Sector: Financial Services
Industry: Drug Manufacturers - Specialty & Generic
Exchange: Frankfurt Stock Exchange


